Display options
Share it on

BMC Res Notes. 2010 Aug 16;3:227. doi: 10.1186/1756-0500-3-227.

Thyroid function tests in patients taking thyroid medication in Germany: Results from the population-based Study of Health in Pomerania (SHIP).

BMC research notes

Anke Hannemann, Nele Friedrich, Robin Haring, Alexander Krebs, Henry Völzke, Dietrich Alte, Matthias Nauck, Thomas Kohlmann, Hans-Christof Schober, Wolfgang Hoffmann, Henri Wallaschofski

Affiliations

  1. Institute of Clinical Chemistry and Laboratory Medicine, Ernst-Moritz-Arndt University Greifswald, Ferdinand-Sauerbruch-Strasse, 17475 Greifswald, Germany. [email protected].

PMID: 20712884 PMCID: PMC2933586 DOI: 10.1186/1756-0500-3-227

Abstract

BACKGROUND: Studies from iodine-sufficient areas have shown that a high proportion of patients taking medication for thyroid diseases have thyroid stimulating hormone (TSH) levels outside the reference range. Next to patient compliance, inadequate dosing adjustment resulting in under- and over-treatment of thyroid disease is a major cause of poor therapy outcomes. Using thyroid function tests, we aim to measure the proportions of subjects, who are under- or over-treated with thyroid medication in a previously iodine-deficient area.

FINDINGS: Data from 266 subjects participating in the population-based Study of Health in Pomerania (SHIP) were analysed. All subjects were taking thyroid medication. Serum TSH levels were measured using immunochemiluminescent procedures. TSH levels of < 0.27 or > 2.15 mIU/L in subjects younger than 50 years and < 0.19 or > 2.09 mIU/L in subjects 50 years and older, were defined as decreased or elevated, according to the established reference range for the specific study area. Our analysis revealed that 56 of 190 (29.5%) subjects treated with thyroxine had TSH levels outside the reference range (10.0% elevated, 19.5% decreased). Of the 31 subjects taking antithyroid drugs, 12 (38.7%) had TSH levels outside the reference range (9.7% elevated, 29.0% decreased). These proportions were lower in the 45 subjects receiving iodine supplementation (2.2% elevated, 8.9% decreased). Among the 3,974 SHIP participants not taking thyroid medication, TSH levels outside the reference range (2.8% elevated, 5.9% decreased) were less frequent.

CONCLUSION: In concordance with previous studies in iodine-sufficient areas, our results indicate that a considerable number of patients taking thyroid medication are either under- or over-treated. Improved monitoring of these patients' TSH levels, compared to the local reference range, is recommended.

References

  1. Postgrad Med J. 2009 Dec;85(1010):655-9 - PubMed
  2. Ann Intern Med. 2000 Feb 15;132(4):270-8 - PubMed
  3. Soz Praventivmed. 2001;46(3):186-94 - PubMed
  4. N Engl J Med. 1994 Nov 10;331(19):1249-52 - PubMed
  5. Arch Intern Med. 2000 Feb 28;160(4):526-34 - PubMed
  6. Br J Gen Pract. 1995 Feb;45(391):93-5 - PubMed
  7. Internist (Berl). 1998 Jun;39(6):619-22 - PubMed
  8. Thyroid. 2004;14 Suppl 1:S17-25 - PubMed
  9. Atherosclerosis. 2001 Mar;155(1):195-200 - PubMed
  10. Br J Gen Pract. 1993 Mar;43(368):107-9 - PubMed
  11. J Clin Endocrinol Metab. 2002 Feb;87(2):489-99 - PubMed
  12. Ann Intern Med. 1990 Aug 15;113(4):265-9 - PubMed
  13. Thyroid. 2007 Dec;17(12):1211-23 - PubMed
  14. Clin Endocrinol (Oxf). 1991 Jan;34(1):77-83 - PubMed
  15. Thyroid. 2004 Nov;14(11):926-32 - PubMed
  16. J Clin Endocrinol Metab. 1990 Sep;71(3):764-9 - PubMed
  17. J Clin Endocrinol Metab. 1998 Mar;83(3):765-9 - PubMed
  18. J Clin Endocrinol Metab. 1998 Oct;83(10):3401-8 - PubMed
  19. Thyroid. 2005 Mar;15(3):279-85 - PubMed
  20. Thyroid. 2003 Aug;13(8):803-10 - PubMed

Publication Types